Health-related QoL in Alpha-1 Antitrypsin Deficiency-Associated COPD - COPD: Peer Perspectives Medpage Today - 15 Apr 2024 Health-related QoL in Alpha-1 Antitrypsin Deficiency-Associated COPD - COPD: Peer Perspectives ... More
Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of ... Yahoo Finance - 26 Mar 2024 Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for the Treatment of ... ... More
Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032, Assesses DelveInsight | Key ... PR Newswire - 18 Jan 2024 Alpha-1 Antitrypsin Deficiency Market to Register Incremental Growth by 2032, Assesses DelveInsight | Key ... ... More
Press Release: Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin ... GlobeNewswire - 23 Jan 2024 Press Release: Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin ... ... More
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends Suggest A USD 2517 Million Valuat PharmiWeb.com - 18 Apr 2024 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends Suggest A USD 2517 Million Valuat ... More
Advanced Infusion Care (AIC) Now Offers Takeda's GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] and ARALAST ... Business Wire - 18 Mar 2024 Advanced Infusion Care (AIC) Now Offers Takeda's GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] and ARALAST ... ... More
Alpha-1 antitrypsin protects against phosgene-induced acute lung injury by activating the ID1-dependent anti ... ScienceDirect.com - 15 Oct 2023 Alpha-1 antitrypsin protects against phosgene-induced acute lung injury by activating the ID1-dependent anti ... ... More
Vertex drops phase 2 lung therapy, rethinks DMD drug's journey toward clinic Fierce Biotech - 07 Nov 2023 Vertex drops phase 2 lung therapy, rethinks DMD drug's journey toward clinic ... More
UK clearance for phase I/II trial of Beam's BEAM-302 for α1-antitrypsin deficiency BioWorld Online - 27 Mar 2024 UK clearance for phase I/II trial of Beam's BEAM-302 for α1-antitrypsin deficiency ... More
CSL Behring Demonstrates Continued Commitment to Alpha-1 Community with Addition of ZEMAIRA® [Alpha1 ... PR Newswire - 02 Jan 2024 CSL Behring Demonstrates Continued Commitment to Alpha-1 Community with Addition of ZEMAIRA® [Alpha1 ... ... More
Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA ... GlobeNewswire - 06 Dec 2023 Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA ... ... More
Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin ScienceDirect.com - 06 Sep 2023 Increased expression or activation of TRPML1 reduces hepatic storage of toxic Z alpha-1 antitrypsin ... More
Alpha 1 Antitrypsin Deficiency Facts & Resources CSL Limited - 01 Jun 2023 Alpha 1 Antitrypsin Deficiency Facts & Resources ... More
Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States ... PR Newswire - 19 Sep 2023 Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States ... ... More
Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT ... GlobeNewswire - 07 Sep 2023 Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT ... ... More
Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency ScienceDirect.com - 13 Jul 2023 Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency ... More
Inhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency PR Newswire - 30 May 2023 Inhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency ... More
Study shows survival benefit of augmentation therapy for people with the genetic lung condition AATD Medical Xpress - 01 Nov 2023 Study shows survival benefit of augmentation therapy for people with the genetic lung condition AATD ... More